Patent 12349941

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

Active provider: Google · gemini-2.5-flash

Ownership chain (1)

Asserters network →

Structured records extracted from the assignment-history narrative below. Each entity links to its full ownership-network profile.

  1. 2024-06-17 · Assignment

    BAYS, F. BARRY; DAYTON, PAULTREACE MEDICAL CONCEPTS, INC.

    internal reorg

Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

✓ Generated

Inventors

  • Paul Dayton: Employed by Treace Medical Concepts, Inc. at the time of filing (implied by the assignment of interest to the company).
  • F. Barry Bays: Employed by Treace Medical Concepts, Inc. at the time of filing (implied by the assignment of interest to the company).
    No unusual patterns (e.g., inventors departing the original assignee) are determinable from the provided patent information.

Original assignee

The entity named on the issued patent is Treace Medical Concepts Inc.
Treace Medical Concepts Inc. is a medical device company headquartered in Ponte Vedra Beach, Florida, specializing in innovative surgical solutions for bunion and midfoot deformities. Their primary line of business involves designing, manufacturing, and marketing proprietary surgical systems, such as the Lapiplasty® 3D Bunion Correction® System, which encompasses instruments, implants, and surgical methods directly related to the "bone positioning and cutting system and method" described in this patent.
The company is currently operating and publicly traded on the Nasdaq stock exchange under the ticker symbol "TMCI," having completed its initial public offering in April 2021. They actively ship products embodying the claims of this patent.

Assignment timeline

I am unable to perform a live search of the USPTO Patent Assignment Search database (https://assignmentcenter.uspto.gov/) to retrieve specific reel/frame numbers and correspondent information. The following assignment record is derived from the "Legal status" section of the Google Patents page for US12349941. Without direct access to the USPTO Assignment Center, detailed correspondent information and specific dates of execution and recording beyond what is stated are not available.

  • 2024-06-17 (executed/recorded) — Reel [N/A]
    • Conveyance: Assignment of Assignors Interest
    • Assignor: BAYS, F. BARRY; DAYTON, PAUL
    • Assignee: Treace Medical Concepts, Inc.
    • Correspondent: [N/A]
    • Context: Internal transfer of inventor's rights to the original assignee.

No other assignments for this patent are explicitly listed in the provided Google Patents legal events section.

Timeline diagram

timeline
    title Ownership of US 12349941
    2014 : Priority date
    2024 : Filed by Treace Medical Concepts
    2024 : Inventors assign to Treace Medical
    2025 : Issued to Treace Medical

NPE / troll-pattern signals

  1. Shell-entity transfer — Not present. The only recorded transfer is from the individual inventors to Treace Medical Concepts, Inc., which is an operating medical device company, not a licensing-only shell entity.
  2. Known asserter in the chain — Not present. Treace Medical Concepts, Inc. is an operating company and is not identified as a known Patent Assertion Entity (NPE) on public lists.
  3. Repeat correspondent across the chain — Unclear. Without access to the USPTO Assignment Center's full records, including correspondent details for the recorded assignment, this signal cannot be assessed.
  4. Cascading transfers — Not present. Only one assignment from the inventors to the initial assignee is noted.
  5. Pre-litigation transfer — Not present. The assignment occurred from inventors to the operating company, and no specific litigation directly involving this patent and predating the assignment is identifiable from the provided information.
  6. Bankruptcy fire-sale — Not present. Treace Medical Concepts, Inc. is an active, publicly traded company.
  7. Privateering — Not present. The patent is held by an operating company that directly markets products related to the claims, indicating direct assertion if litigation occurs.
  8. Defensive aggregator (anti-NPE) — Not present. The patent is owned by an operating company, not a defensive aggregator.

Verdict

Operating-company assertion
The patent is currently owned by Treace Medical Concepts, Inc., which is an active medical device company engaged in the design, manufacture, and sale of surgical systems for bunion and midfoot deformities. The only recorded assignment is from the individual inventors to this operating company on 2024-06-17, a typical transfer for employee-inventors. There are no signals suggesting a transfer to a non-practicing entity or any other troll-pattern behavior.

(For verification, please search US12349941 at https://assignmentcenter.uspto.gov/)

Generated 5/29/2026, 5:40:10 PM